Adline Chem Lab Ltd Stock Price Today (NSE: ADLINE)
Fundamental Score
Adline Chem Lab Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Adline Chem Lab Ltd share price today is ₹12.50, up +0.00% on NSE/BSE as of 30 March 2026. Adline Chem Lab Ltd (ADLINE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹4.91 (Cr). The 52-week high for ADLINE share price is ₹19.08 and the 52-week low is ₹7.60.
Adline Chem Lab Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Adline Chem Lab Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Adline Chem Lab Share Price: A Concerning Financial Outlook
The pharmaceutical industry, despite its defensive nature, demands efficient capital allocation to navigate pricing pressures and evolving regulations. This financial analysis focuses on the Adline Chem Lab share price, currently trading at ₹14.75. A critical concern arises immediately: the absence of a Price-to-Earnings (PE) ratio and a Return on Capital Employed (ROCE). The lack of a PE suggests the company may not be profitable, hindering valuation based on earnings. A missing ROCE figure, often a strong indicator of management effectiveness, signals difficulties in generating returns from invested capital.
A crucial element of long-term investment is a company's ability to build a sustainable competitive advantage, or economic moat. The reported "None%" ROCE for Adline Chem Lab significantly undermines any potential moat. Without a healthy ROCE, the company struggles to reinvest profits effectively, innovate, and maintain pricing power. Compare this to
Mankind Pharma Ltd, a peer known for its disciplined capital deployment and strategic brand building, often associated with strong management quality. A stark contrast suggests Adline Chem Lab may face challenges in operational efficiency and strategic decision-making.Considering sector peers such as Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, a deeper dive into their financial metrics becomes necessary to benchmark Adline Chem Lab's performance. Are these peers exhibiting similar challenges in profitability and capital efficiency? While a low share price might appear attractive, the missing financial metrics raise serious questions about the underlying health and future prospects of the business. Potential investors should proceed with extreme caution.
Disclaimer: This analysis of the Adline Chem Lab share price is observational and based on publicly available data as of today's date. It forms part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, to assess the company's overall financial strength. This analysis does not constitute financial advice and is not a recommendation to buy or sell any securities. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Adline Chem Lab Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ADLINE across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Robust Profit Growth (22.22%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Weak Interest Coverage (0.08x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-0.35 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (29.61%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Adline Chem Lab Ltd Financial Statements
Comprehensive financial data for Adline Chem Lab Ltd including income statement, balance sheet and cash flow
About ADLINE (Adline Chem Lab Ltd)
Adline Chem Lab Ltd is a pioneering force in the pharmaceutical and biotechnology sectors, dedicated to advancing global health through innovative research, development, and manufa...cturing. With a steadfast commitment to scientific excellence, ADLINE strives to address unmet medical needs and improve patient outcomes worldwide. The company's core values of integrity, quality, and innovation underpin every aspect of its operations, from cutting-edge research laboratories to state-of-the-art manufacturing facilities. ADLINE is driven by a team of highly skilled scientists, engineers, and healthcare professionals who are passionate about pushing the boundaries of medical science and delivering life-changing therapies to those who need them most. ADLINE's diverse portfolio of pharmaceutical and biotechnology products encompasses a wide range of therapeutic areas, reflecting its dedication to comprehensive healthcare solutions. The company specializes in developing and commercializing novel treatments for infectious diseases, gastrointestinal disorders, and musculoskeletal conditions, addressing critical healthcare challenges faced by patients across the globe. Furthermore, ADLINE provides essential medicines for pediatric care, women's health, and respiratory ailments, ensuring that patients of all ages have access to high-quality healthcare solutions. These products are available in various formulations, including tablets, capsules, liquids, and injectables, to cater to diverse patient needs and preferences. Beyond its commitment to human health, ADLINE also extends its expertise to veterinary medicine, providing animal healthcare solutions that promote the well-being of pets and livestock. The company develops and manufactures a range of veterinary pharmaceuticals and nutritional supplements, addressing the specific health needs of animals and supporting the agricultural industry. Additionally, ADLINE is dedicated to advancing medical knowledge through educational initiatives, providing healthcare professionals with the latest scientific insights and clinical guidelines. This holistic approach to healthcare, encompassing both human and animal well-being, positions ADLINE as a trusted partner in promoting global health and improving the quality of life for all.
Company Details
Key Leadership
Latest News
ADLINE Share Price: Frequently Asked Questions
What is the current share price of Adline Chem Lab Ltd (ADLINE)?
As of 30 Mar 2026, 11:00 am IST, Adline Chem Lab Ltd share price is ₹12.50. The ADLINE stock has a market capitalisation of ₹4.91 (Cr) on NSE/BSE.
Is ADLINE share price Overvalued or Undervalued?
ADLINE share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Adline Chem Lab Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ADLINE share price?
The 52-week high of ADLINE share price is ₹19.08 and the 52-week low is ₹7.60. These values are updated daily from NSE/BSE price data.
What factors affect the Adline Chem Lab Ltd share price?
Key factors influencing ADLINE share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Adline Chem Lab Ltd a good stock for long-term investment?
Adline Chem Lab Ltd shows a 5-year Profit Growth of 14.49% and an ROE of N/A%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in ADLINE shares.
How does Adline Chem Lab Ltd compare with its industry peers?
Adline Chem Lab Ltd competes with major peers in the Pharmaceuticals. Investors should compare ADLINE share price P/E of 0.00x and ROE of N/A% against the industry averages to determine competitive standing.
What is the P/E ratio of ADLINE and what does it mean?
ADLINE share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ADLINE performing according to Bull Run's analysis?
ADLINE has a Bull Run fundamental score of 14.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ADLINE belong to?
ADLINE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Adline Chem Lab Ltd share price.
What is Return on Equity (ROE) and why is it important for ADLINE?
ADLINE has an ROE of N/A%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Adline Chem Lab Ltd generates profits from shareholders capital.
How is ADLINE debt-to-equity ratio and what does it indicate?
ADLINE has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is ADLINE dividend yield and is it a good dividend stock?
ADLINE offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Adline Chem Lab Ltd shares.
How has ADLINE share price grown over the past 5 years?
ADLINE has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 14.49%, and EPS Growth 14.49%.
What is the promoter holding in ADLINE and why does it matter?
Promoters hold 29.61% of ADLINE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Adline Chem Lab Ltd.
What is ADLINE market capitalisation category?
ADLINE has a market capitalisation of ₹5 crores, placing it in the Small-cap category.
How volatile is ADLINE stock?
ADLINE has a beta of N/A. A beta > 1 suggests the Adline Chem Lab Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ADLINE operating profit margin trend?
ADLINE has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is ADLINE quarterly performance?
Recent quarterly performance shows Adline Chem Lab Ltd YoY Sales Growth of N/A% and YoY Profit Growth of 22.22%.
What is the institutional holding pattern in ADLINE?
ADLINE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Adline Chem Lab Ltd stock.